Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Efficacy of Empagliflozin Versus Statins in Treatment of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

NCT07180745 is registered in ClinicalTrials.gov with Badr University as lead sponsor.

NCT NCT07180745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07180745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Efficacy of Empagliflozin Versus Statins in Treatment of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Lead sponsor
Badr University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 1, 2025
Completion date
March 1, 2026
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic fatty liver disease nafld, non-alcoholic steatohepatitis nash